Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, 149 13th Street, Charlestown, MA 02129, USA; Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, 149 13th Street, Charlestown, MA 02129, USA; Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
Hematol Oncol Clin North Am. 2024 Oct;38(5):939-952. doi: 10.1016/j.hoc.2024.05.005. Epub 2024 Jun 15.
Cutaneous melanoma is an aggressive form of skin cancer derived from skin melanocytes and is associated with significant morbidity and mortality. A significant fraction of melanomas are associated with precursor lesions, benign clonal proliferations of melanocytes called nevi. Nevi can be either congenital or acquired later in life. Identical oncogenic driver mutations are found in benign nevi and melanoma. While much progress has been made in our understanding of nevus formation and the molecular steps required for transformation of nevi into melanoma, the clinical diagnosis of benign versus malignant lesions remains challenging.
皮肤黑素瘤是一种源自皮肤黑素细胞的侵袭性皮肤癌,具有显著的发病率和死亡率。很大一部分黑素瘤与前驱病变有关,即良性克隆性黑素细胞增殖,称为痣。痣可以是先天性的,也可以是后天获得的。良性痣和黑色素瘤中发现了相同的致癌驱动突变。尽管我们在了解痣的形成以及痣向黑色素瘤转化所需的分子步骤方面取得了很大进展,但良性与恶性病变的临床诊断仍然具有挑战性。